Identification of a Novel Non-V600E BRAF Mutation in Papillary Thyroid Cancer
Papillary thyroid cancer (PTC) is a common endocrine malignancy, and its incidence is reported to be constantly increasing. BRAF mutation is detected in approximately 44% of PTCs, and the most common BRAF mutation is thymine (T) to adenine (A) missense mutation in nucleotide 1796 (T1796A, V600E). Al...
Saved in:
Main Authors: | Marco Capezzone, Maja Rossi, Elisabetta Macerola, Silvia Cantara, Francesco Pepe, Eugenia Maria Morabito, Gilda Dalmazio, Sara Bardi, Agostino Ognibene, Massimo Alessandri, Gabriele Materazzi, Luigi De Napoli, Michele Cirianni, Liborio Torregrossa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2024/6621510 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In-depth characterization of miRNome in papillary thyroid cancer with BRAF V600E mutation
by: Azliana Mohamad Yusof, et al.
Published: (2020-03-01) -
The Prognostic Implication of the BRAF V600E Mutation in Papillary Thyroid Cancer in a Chinese Population
by: Ziheng Ye, et al.
Published: (2022-01-01) -
BRAF V600E-Negative Hairy Cell Leukaemia
by: Stephen E. Langabeer, et al.
Published: (2013-01-01) -
BRAF Inhibitors for BRAF V600E Mutant Colorectal Cancers: Literature Survey and Case Report
by: Yasar Subutay Peker, et al.
Published: (2018-01-01) -
A BRAF V600E Mutation in RET-Negative Medullary Thyroid Cancer
by: Richard J. Robbins, et al.
Published: (2020-01-01)